NEW YORK--(BUSINESS WIRE)--Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, reminds investors that October 17, 2017, is the deadline to move for lead plaintiff status in the securities class action pending against Depomed, Inc. (“Depomed” or the “Company”) (NASDAQ: DEPO). If you purchased Depomed shares between February 26, 2015 and August 7, 2017, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for more information.
Depomed is a specialty pharmaceutical company focused on pain and other central nervous system conditions. The lawsuit alleges that, during the Class Period, Depomed made false and misleading statements regarding the Company’s questionable practices in connection with the sales and marketing of its opioid products.
On August 7, 2017, after the market closed, Depomed announced that it “recently received a request for information from the ranking minority member of the United States Senate Committee on Homeland Security and Governmental Affairs related to the promotion of opioids” as well as “subpoenas related to opioid sales and marketing from the Office of the Attorney General of Maryland and the United States Department of Justice.”
Following this news, Depomed’s stock price declined from a close of $9.23 on August 7th to close at $6.15 on August 8th – a drop of over 33%.
What You Can Do
If you purchased Depomed stock between February 26, 2015 and August 7, 2017 and you wish to discuss this lawsuit, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew at (844) 818-6982, or at email@example.com. The deadline to move for Lead Plaintiff status is October 17, 2017.
About Scott+Scott, Attorneys at Law, LLP
Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.